Modular Medical, Inc. (MODD) Stock Score, Valuation & Financial Research

Modular Medical, Inc. is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for MODD

Modular Medical, Inc. does not currently have a complete Wall Street Score. The stored market price is USD 2.73. These figures are a research snapshot, not a buy or sell recommendation.

What Modular Medical, Inc. does

Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.

Company business and revenue

Research reporting period: 2026-03-31. A research update is not a new financial filing.

How the company makes money

Modular Medical is a commercial-stage medical device company that designs and develops insulin pumps. Its business model focuses on the eventual commercialization of these devices to increase pump adoption in the diabetes marketplace, utilizing a modular design and low-cost components to improve affordability and user-friendliness.

Products and services

  • The company is developing insulin pump technology, specifically the MODD1 and Pivot pump models, which are designed as two-part patch pumps for individuals with type-1 and type-2 diabetes.

Brands and product families

  • Pivot — Insulin pump model designed for user-friendliness and affordability. Source
  • MODD1 — Two-part patch pump for diabetes management. Source

Customer types

People with type-1 diabetes; People with type-2 diabetes.

Suppliers, materials and equipment

  • Phillips Medisize — Contract manufacturer responsible for production assembly of insulin pumps. Source

Business relationships and partnerships

  • Phillips Medisize — A tier-one medical device manufacturer contracted to manage and operate the production assembly lines for the company's insulin pumps. Source

Business strengths to evaluate

  • Modular design and low-cost components Source

Business risks and research considerations

  • Dependence on third-party manufacturing partners Source
  • Regulatory approval requirements Source

Sources: Company research source · Phillips Medisize · Regulatory approval requirements

Company research refreshed 2026-10-13. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

MODD financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 2.73
Market capitalization:
22.25M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD -28.03M
Free cash flow:
USD -27.69M
Cash:
USD 3.92M
Total debt:
USD 278K
EPS:
USD -10.06

What stands out

  • Free cash flow is USD -27.69M, negative for the stored period.
  • The balance sheet shows USD 3.92M of cash versus USD 278K of total debt, an excess of cash over debt on these two reported measures.
  • The current research record carries a fundamental change risk warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Cash exceeds debt by USD 3.64M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for MODD

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can MODD fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • How is MODD likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • What specifically needs to improve for MODD to reach sustainable profitability?
  • What does the current fundamental change risk warning mean for the reliability or interpretation of MODD's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-05.

Research-input completeness: 73% of the scoring inputs required for this public page are currently available.

How to research MODD

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.